September 2020 FAQs
- What data supports imipenem-cilastatin/relebactam’s new indication for bacterial pneumonia?
- What information is available regarding screening and treating asymptomatic bacteriuria prior to select nonurologic surgeries?
- Update: What data support the use of andexanet alfa (ANDEXXA) for the reversal of factor Xa inhibitors?
- What do pharmacists need to know about the Emergency Use Authorization for convalescent plasma for COVID-19?